TitleAssistant Professor
InstitutionMD Anderson
DepartmentBreast Medical Oncology
Address1155 Pressler St
Houston TX 77030-3721
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Woodfin AA, Yam C, Teshome M, Kuerer HM, Hunt KK, Meric-Bernstam F, Schaverien M, Barcenas CH, Sun SX. Axillary Nodal Metastases Conversion and Perioperative Complications with Neoadjuvant Pembrolizumab Therapy in Triple-Negative Breast Cancer. Ann Surg Oncol. 2024 Feb; 31(2):974-980. PMID: 37973647.
      Citations:    Fields:    Translation:Humans
    2. Chido-Amajuoyi OG, Onyeaka HK, Sokale IO, Nwani S, Barcenas CH, Amonoo HL, Shete S. Political Ideology and Trust in Government Health Agencies for Cancer Information. JAMA Netw Open. 2023 Nov 01; 6(11):e2341191. PMID: 37921773; PMCID: PMC10625042.
      Citations:    Fields:    Translation:Humans
    3. Prinsloo S, Kaptchuk TJ, De Ridder D, Lyle R, Bruera E, Novy D, Barcenas CH, Cohen LG. Brain-computer interface relieves chronic chemotherapy-induced peripheral neuropathy: A randomized, double-blind, placebo-controlled trial. Cancer. 2024 01; 130(2):300-311. PMID: 37733286.
      Citations: 1     Fields:    Translation:Humans
    4. Jayan A, Raghavendra AS, Bassett R, Barcenas CH. Bone-Targeted Therapy Regimen and Skeletal-Related Events in Patients Surviving Longer Than 2 Years With Metastatic Breast Cancer and Bone Metastasis. Clin Breast Cancer. 2023 12; 23(8):e515-e522. PMID: 37735019.
      Citations:    Fields:    
    5. Gandhi A, Xu T, DeSnyder SM, Smith GL, Lin R, Barcenas CH, Stauder MC, Hoffman KE, Strom EA, Ferguson S, Smith BD, Woodward WA, Perkins GH, Mitchell MP, Garner D, Goodman CR, Aldrich M, Travis M, Lilly S, Bedrosian I, Shaitelman SF. Prospective, early longitudinal assessment of lymphedema-related quality of life among patients with locally advanced breast cancer: The foundation for building a patient-centered screening program. Breast. 2023 Apr; 68:205-215. PMID: 36863241; PMCID: PMC9996356.
      Citations:    Fields:    Translation:Humans
    6. Abraham A, Barcenas CH, Bleicher RJ, Cohen AL, Javid SH, Levine EG, Lin NU, Moy B, Niland JC, Wolff AC, Hassett MJ, Asad S, Stover DG. Clinicopathologic and sociodemographic factors associated with late relapse triple negative breast cancer in a multivariable logistic model: A multi-institution cohort study. Breast. 2023 Feb; 67:89-93. PMID: 36681001; PMCID: PMC9982264.
      Citations: 1     Fields:    Translation:Humans
    7. Chan A, Ruiz-Borrego M, Marx G, Chien AJ, Rugo HS, Brufsky A, Thirlwell M, Trudeau M, Bose R, Garc?a-S?enz JA, Egle D, Pistilli B, Wassermann J, Cheong KA, Schnappauf B, Semsek D, Singer CF, Foruzan N, DiPrimeo D, McCulloch L, Hurvitz SA, Barcenas CH. Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer. Breast. 2023 Feb; 67:94-101. PMID: 36702070; PMCID: PMC9982309.
      Citations:    Fields:    Translation:Humans
    8. Aldrich MB, Rasmussen JC, DeSnyder SM, Woodward WA, Chan W, Sevick-Muraca EM, Mittendorf EA, Smith BD, Stauder MC, Strom EA, Perkins GH, Hoffman KE, Mitchell MP, Barcenas CH, Isales LE, Shaitelman SF. Prediction of breast cancer-related lymphedema by dermal backflow detected with near-infrared fluorescence lymphatic imaging. Breast Cancer Res Treat. 2022 Aug; 195(1):33-41. PMID: 35816269; PMCID: PMC9272652.
      Citations:    Fields:    
    9. Wu LR, Dai P, Wang MX, Chen SX, Cohen EN, Jayachandran G, Zhang JX, Serrano AV, Xie NG, Ueno NT, Reuben JM, Barcenas CH, Zhang DY. Ensemble of nucleic acid absolute quantitation modules for copy number variation detection and RNA profiling. Nat Commun. 2022 04 04; 13(1):1791. PMID: 35379811; PMCID: PMC8979981.
      Citations:    Fields:    Translation:Humans
    10. Singareeka Raghavendra A, Kypriotakis G, Karam-Hage M, Kim S, Jizzini M, Seoudy KS, Robinson JD, Barcenas CH, Cinciripini PM, Tripathy D, Ibrahim NK. The Impact of Treatment for Smoking on Breast Cancer Patients' Survival. Cancers (Basel). 2022 Mar 12; 14(6). PMID: 35326615; PMCID: PMC8946483.
    11. Barcenas CH, Song J, Murthy RK, Raghavendra AS, Li Y, Hsu L, Carlson RW, Tripathy D, Hortobagyi GN. Reply to A. Pfob and C. Sidey-Gibbons. JCO Clin Cancer Inform. 2022 02; 6:e2100171. PMID: 35175860.
      Citations:    Fields:    Translation:Humans
    12. Diao K, Andring LM, Barcenas CH, Singh P, Carisa Le-Petross H, Reed VK, Reddy JP, Bloom ES, Ahmad NR, Mayo LL, Perkins GH, Mitchell MP, Nead KT, Tereffe W, Smith BD, Woodward WA. Contemporary Outcomes After Multimodality Therapy in Patients With Breast Cancer Presenting With Ipsilateral Supraclavicular Node Involvement. Int J Radiat Oncol Biol Phys. 2022 01 01; 112(1):66-74. PMID: 34710521; PMCID: PMC8688264.
      Citations:    Fields:    Translation:Humans
    13. Barcenas CH, Song J, Murthy RK, Raghavendra AS, Li Y, Hsu L, Carlson RW, Tripathy D, Hortobagyi GN. Prognostic Model for De Novo and Recurrent Metastatic Breast Cancer. JCO Clin Cancer Inform. 2021 08; 5:789-804. PMID: 34351787; PMCID: PMC8807018.
      Citations:    Fields:    Translation:Humans
    14. Elmore LC, Kuerer HM, Barcenas CH, Smith BD, Miggins MV, Lucci A, Caudle AS, Meric-Bernstam F, Hunt KK, Teshome M. Clinical Course of Breast Cancer Patients with Local-Regional Progression During Neoadjuvant Systemic Therapy. Ann Surg Oncol. 2021 Oct; 28(10):5477-5485. PMID: 34247335.
      Citations: 1     Fields:    Translation:Humans
    15. Singareeka Raghavendra A, Alameddine HF, Andersen CR, Selber JC, Brewster AM, Barcenas CH, Caudle AS, Arun BK, Tripathy D, Ibrahim NK. Influencers of the Decision to Undergo Contralateral Prophylactic Mastectomy among Women with Unilateral Breast Cancer. Cancers (Basel). 2021 Apr 23; 13(9). PMID: 33922702; PMCID: PMC8123066.
    16. Asad S, Barcenas CH, Bleicher RJ, Cohen AL, Javid SH, Levine EG, Lin NU, Moy B, Niland J, Wolff AC, Hassett MJ, Stover DG. Sociodemographic Factors Associated With Rapid Relapse in Triple-Negative Breast Cancer: A Multi-Institution Study. J Natl Compr Canc Netw. 2021 03 10; 19(7):797-804. PMID: 33691275; PMCID: PMC8564718.
      Citations: 5     Fields:    Translation:Humans
    17. Jackisch C, Barcenas CH, Bartsch R, Palma JD, Harbeck N, Macedo G, O'Shaughnessy J, Pistilli B, Ruiz-Borrego M, Rugo HS, Gl?ck S. Optimal Strategies for Successful Initiation of Neratinib in Patients with HER2-Positive Breast Cancer. Clin Breast Cancer. 2021 10; 21(5):e575-e583. PMID: 33678567.
      Citations: 4     Fields:    Translation:Humans
    18. Lei X, Giordano SH, Valero V, Barcenas CH, Hortobagyi GN, Chavez-MacGregor M, de Melo Gagliato D. Impact of Delayed Neoadjuvant Systemic Chemotherapy on Overall Survival Among Patients with Breast Cancer. Oncologist. 2020 09; 25(9):749-757. PMID: 32431013; PMCID: PMC7485349.
      Citations: 5     Fields:    Translation:Humans
    19. Berkman AM, Livingston JA, Merriman K, Hildebrandt M, Wang J, Dibaj S, McQuade J, You N, Ying A, Barcenas C, Bodurka D, DePombo A, Lee HJ, de Groot J, Roth M. Long-term survival among 5-year survivors of adolescent and young adult cancer. Cancer. 2020 08 15; 126(16):3708-3718. PMID: 32484922; PMCID: PMC7381371.
      Citations: 10     Fields:    Translation:Humans
    20. Barcenas CH, Hurvitz SA, Di Palma JA, Bose R, Chien AJ, Iannotti N, Marx G, Brufsky A, Litvak A, Ibrahim E, Alvarez RH, Ruiz-Borrego M, Chan N, Manalo Y, Kellum A, Trudeau M, Thirlwell M, Hunt D, Bryce R, McCulloch L, Rugo HS, Tripathy D, Chan A, CONTROL Study Investigators, Garcia Saenz J. Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial. Ann Oncol. 2020 09; 31(9):1223-1230. PMID: 32464281.
      Citations: 19     Fields:    Translation:HumansCTClinical Trials
    21. Chun YS, Mizuno T, Cloyd JM, Ha MJ, Omichi K, Tzeng CD, Aloia TA, Ueno NT, Kuerer HM, Barcenas CH, Vauthey JN. Hepatic resection for breast cancer liver metastases: Impact of intrinsic subtypes. Eur J Surg Oncol. 2020 09; 46(9):1588-1595. PMID: 32253074; PMCID: PMC7434695.
      Citations: 7     Fields:    Translation:Humans
    22. Le Du F, Fujii T, Kida K, Davis DW, Park M, Liu DD, Wu W, Chavez-MacGregor M, Barcenas CH, Valero V, Tripathy D, Reuben JM, Ueno NT. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream? in patients with breast cancer treated with primary systemic therapy. PLoS One. 2020; 15(3):e0229903. PMID: 32214335; PMCID: PMC7098555.
      Citations: 13     Fields:    Translation:HumansCells
    23. Murthy RK, Song J, Raghavendra AS, Li Y, Hsu L, Hess KR, Barcenas CH, Valero V, Tripathy D, Hortobagyi GN, Carlson RW. Incorporation of clinical and biological factors improves prognostication and reflects contemporary clinical practice. NPJ Breast Cancer. 2020; 6:11. PMID: 32219153; PMCID: PMC7096449.
      Citations: 1     
    24. Chen E, Abu-Sbeih H, Thirumurthi S, Mallepally N, Khurana S, Wei D, Altan M, Morris VK, Tan D, Barcenas CH, Wang Y. Clinical characteristics of colitis induced by taxane-based chemotherapy. Ann Gastroenterol. 2020 Jan-Feb; 33(1):59-67. PMID: 31892799; PMCID: PMC6928479.
      Citations: 3     
    25. Litton JK, Scoggins ME, Hess KR, Adrada BE, Murthy RK, Damodaran S, DeSnyder SM, Brewster AM, Barcenas CH, Valero V, Whitman GJ, Schwartz-Gomez J, Mittendorf EA, Thompson AM, Helgason T, Ibrahim N, Piwnica-Worms H, Moulder SL, Arun BK. Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline BRCA Pathogenic Variant. J Clin Oncol. 2020 02 10; 38(5):388-394. PMID: 31461380; PMCID: PMC7351336.
      Citations: 51     Fields:    Translation:HumansCTClinical Trials
    26. Sinha AK, Moye L, Piller LB, Yamal JM, Barcenas CH, Lin J, Davis BR. Adaptive group-sequential design with population enrichment in phase 3 randomized controlled trials with two binary co-primary endpoints. Stat Med. 2019 09 20; 38(21):3985-3996. PMID: 31184783.
      Citations:    Fields:    Translation:Humans
    27. Abu-Sbeih H, Ali FS, Ge PS, Barcenas CH, Lum P, Qiao W, Bresalier RS, Bhutani MS, Raju GS, Wang Y. Patients with breast cancer may be at higher risk of colorectal neoplasia. Ann Gastroenterol. 2019 Jul-Aug; 32(4):400-406. PMID: 31263363; PMCID: PMC6595931.
      Citations: 4     
    28. Lim B, Murthy RK, Lee J, Jackson SA, Iwase T, Davis DW, Willey JS, Wu J, Shen Y, Tripathy D, Alvarez R, Ibrahim NK, Brewster AM, Barcenas CH, Brown PH, Giordano SH, Moulder SL, Booser DJ, Moscow JA, Piekarz R, Valero V, Ueno NT. A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment. Br J Cancer. 2019 06; 120(12):1105-1112. PMID: 31097774; PMCID: PMC6738035.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    29. Baez-Vallecillo L, Raghavendra AS, Hess KR, Barcenas CH, Moulder SL, Tripathy D, Valero V, Murthy RK. Lapatinib activity in metastatic human epidermal growth factor receptor 2-positive breast cancers that received prior therapy with trastuzumab, pertuzumab, and/or ado-trastuzumab emtansine (T-DM1). Breast Cancer Res Treat. 2019 Jul; 176(1):227-234. PMID: 30977027.
      Citations: 6     Fields:    Translation:Humans
    30. Christopherson K, Lei X, Barcenas C, Buchholz TA, Garg N, Hoffman KE, Kuerer HM, Mittendorf E, Perkins G, Shaitelman SF, Smith GL, Stauder M, Strom EA, Tereffe W, Woodward WA, Smith BD. Outcomes of Curative-Intent Treatment for Patients With Breast Cancer Presenting With Sternal or Mediastinal Involvement. Int J Radiat Oncol Biol Phys. 2019 07 01; 104(3):574-581. PMID: 30851348; PMCID: PMC6548669.
      Citations: 2     Fields:    Translation:Humans
    31. Karuturi MS, Holmes HM, Lei X, Johnson M, Barcenas CH, Cantor SB, Gallick GE, Bast RC, Giordano SH. Potentially inappropriate medications defined by STOPP criteria in older patients with breast and colorectal cancer. J Geriatr Oncol. 2019 09; 10(5):705-708. PMID: 30795923; PMCID: PMC6699920.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    32. Tadros AB, Smith BD, Shen Y, Lin H, Krishnamurthy S, Lucci A, Barcenas CH, Hwang RF, Rauch G, Santiago L, Strom EA, DeSnyder SM, Yang WT, Black DM, Albarracin CT, Chavez-MacGregor M, Hunt KK, Kuerer HM. Ductal Carcinoma In Situ and Margins <2?mm: Contemporary Outcomes With Breast Conservation. Ann Surg. 2019 01; 269(1):150-157. PMID: 28742682; PMCID: PMC6051916.
      Citations: 12     Fields:    Translation:Humans
    33. Wong Y, Raghavendra AS, Hatzis C, Irizarry JP, Vega T, Horowitz N, Barcenas CH, Chavez-MacGregor M, Valero V, Tripathy D, Pusztai L, Murthy RK. Long-Term Survival of De Novo Stage IV Human Epidermal Growth Receptor 2 (HER2) Positive Breast Cancers Treated with HER2-Targeted Therapy. Oncologist. 2019 03; 24(3):313-318. PMID: 30139836; PMCID: PMC6519755.
      Citations: 9     Fields:    Translation:Humans
    34. Murthy RK, Raghavendra AS, Hess KR, Fujii T, Lim B, Barcenas CH, Zhang H, Chavez-Mac-Gregor M, Mittendorf EA, Litton JK, Giordano SH, Thompson AM, Valero V, Moulder SL, Tripathy D, Ueno NT. Neoadjuvant Pertuzumab-containing Regimens Improve Pathologic Complete Response Rates in Stage II to III HER-2/neu-positive Breast Cancer: A Retrospective, Single Institution Experience. Clin Breast Cancer. 2018 12; 18(6):e1283-e1288. PMID: 30077429.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    35. Stecklein SR, Park M, Liu DD, Valle Goffin JJ, Caudle AS, Mittendorf EA, Barcenas CH, Mougalian S, Woodward WA, Valero V, Sahin AA, Yang WT, Shaitelman SF. Long-Term Impact of Regional Nodal Irradiation in Patients With Node-Positive Breast Cancer Treated With Neoadjuvant Systemic Therapy. Int J Radiat Oncol Biol Phys. 2018 11 01; 102(3):568-577. PMID: 29928946.
      Citations: 2     Fields:    Translation:Humans
    36. Barcenas CH, Shafaee MN, Sinha AK, Raghavendra A, Saigal B, Murthy RK, Woodson AH, Arun B. Genetic Counseling Referral Rates in Long-Term Survivors of Triple-Negative Breast Cancer. J Natl Compr Canc Netw. 2018 05; 16(5):518-524. PMID: 29752326; PMCID: PMC5978679.
      Citations: 4     Fields:    Translation:Humans
    37. Karuturi MS, Holmes HM, Lei X, Johnson M, Barcenas CH, Cantor SB, Gallick GE, Bast RC, Giordano SH. Potentially inappropriate medication use in older patients with breast and colorectal cancer. Cancer. 2018 07 15; 124(14):3000-3007. PMID: 29689595; PMCID: PMC6033638.
      Citations: 15     Fields:    Translation:Humans
    38. Raghavendra A, Sinha AK, Valle-Goffin J, Shen Y, Tripathy D, Barcenas CH. Determinants of Weight Gain During Adjuvant Endocrine Therapy and Association of Such Weight Gain With Recurrence in Long-term Breast Cancer Survivors. Clin Breast Cancer. 2018 02; 18(1):e7-e13. PMID: 29239836; PMCID: PMC5937690.
      Citations: 5     Fields:    Translation:Humans
    39. Fujii T, Reuben JM, Huo L, Espinosa Fernandez JR, Gong Y, Krupa R, Suraneni MV, Graf RP, Lee J, Greene S, Rodriguez A, Dugan L, Louw J, Lim B, Barcenas CH, Marx AN, Tripathy D, Wang Y, Landers M, Dittamore R, Ueno NT. Androgen receptor expression on circulating tumor cells in metastatic breast cancer. PLoS One. 2017; 12(9):e0185231. PMID: 28957377; PMCID: PMC5619732.
      Citations: 10     Fields:    Translation:HumansCells
    40. Zhang X, Sun M, McKoy JM, Bhulani NNA, Valero V, Barcenas CH, Popat UR, Sri MK, Shah JB, Dinney CP, Hedberg AM, Champlin R, Tripathy D, Holmes HM, Stroehlein JR, Edwards BJ. Malnutrition in older patients with cancer: Appraisal of the Mini Nutritional Assessment, weight loss, and body mass index. J Geriatr Oncol. 2018 01; 9(1):81-83. PMID: 28844850.
      Citations: 3     Fields:    Translation:Humans
    41. Kuerer HM, Smith BD, Chavez-MacGregor M, Albarracin C, Barcenas CH, Santiago L, Edgerton ME, Rauch GM, Giordano SH, Sahin A, Krishnamurthy S, Woodward W, Tripathy D, Yang WT, Hunt KK. DCIS Margins and Breast Conservation: MD Anderson Cancer Center Multidisciplinary Practice Guidelines and Outcomes. J Cancer. 2017; 8(14):2653-2662. PMID: 28928852; PMCID: PMC5604195.
      Citations: 14     
    42. Ayoub Z, Strom EA, Ovalle V, Perkins GH, Woodward WA, Tereffe W, Smith BD, Shaitelman SF, Stauder MC, Hoffman KE, DeSnyder SM, Garvey PB, Clemens MW, Barcenas CH, Kuerer HM, Kronowitz S. A 10-Year Experience with Mastectomy and Tissue Expander Placement to Facilitate Subsequent Radiation and Reconstruction. Ann Surg Oncol. 2017 Oct; 24(10):2965-2971. PMID: 28766219.
      Citations: 3     Fields:    Translation:Humans
    43. Tadros AB, Yang WT, Krishnamurthy S, Rauch GM, Smith BD, Valero V, Black DM, Lucci A, Caudle AS, DeSnyder SM, Teshome M, Barcenas CH, Miggins M, Adrada BE, Moseley T, Hwang RF, Hunt KK, Kuerer HM. Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery. JAMA Surg. 2017 07 01; 152(7):665-670. PMID: 28423171; PMCID: PMC5547923.
      Citations: 39     Fields:    Translation:Humans
    44. Wu X, Ye Y, Barcenas CH, Chow WH, Meng QH, Chavez-MacGregor M, Hildebrandt MA, Zhao H, Gu X, Deng Y, Wagar E, Esteva FJ, Tripathy D, Hortobagyi GN. Personalized Prognostic Prediction Models for Breast Cancer Recurrence and Survival Incorporating Multidimensional Data. J Natl Cancer Inst. 2017 07 01; 109(7). PMID: 28376179; PMCID: PMC6279311.
      Citations: 18     Fields:    Translation:Humans
    45. Fayanju OM, Hall CS, Bauldry JB, Karhade M, Valad LM, Kuerer HM, DeSnyder SM, Barcenas CH, Lucci A. Body mass index mediates the prognostic significance of circulating tumor cells in inflammatory breast cancer. Am J Surg. 2017 Oct; 214(4):666-671. PMID: 28720217; PMCID: PMC5770232.
      Citations: 5     Fields:    Translation:HumansCells
    46. Cropper C, Woodson A, Arun B, Barcenas C, Litton J, Noblin S, Liu D, Park M, Daniels M. Evaluating the NCCN Clinical Criteria for Recommending BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer. J Natl Compr Canc Netw. 2017 06; 15(6):797-803. PMID: 28596260.
      Citations: 4     Fields:    Translation:Humans
    47. Barcenas CH, Raghavendra A, Sinha AK, Syed MP, Hsu L, Patangan MG, Chavez-MacGregor M, Shen Y, Hortobagyi GH, Valero V, Giordano SH, Ueno NT, Tripathy D. Outcomes in patients with early-stage breast cancer who underwent a 21-gene expression assay. Cancer. 2017 Jul 01; 123(13):2422-2431. PMID: 28199747; PMCID: PMC5568788.
      Citations: 13     Fields:    Translation:Humans
    48. Raghavendra A, Sinha AK, Le-Petross HT, Garg N, Hsu L, Patangan M, Bevers TB, Shen Y, Banu A, Tripathy D, Bedrosian I, Barcenas CH. Mammographic breast density is associated with the development of contralateral breast cancer. Cancer. 2017 06 01; 123(11):1935-1940. PMID: 28135395; PMCID: PMC5577931.
      Citations: 10     Fields:    Translation:Humans
    49. Sinha AK, Patel JR, Shen Y, Ueno NT, Giordano SH, Tripathy D, Lopez DS, Barcenas CH. Location of Receipt of Initial Treatment and Outcomes in Long-Term Breast Cancer Survivors. PLoS One. 2017; 12(1):e0170081. PMID: 28085940; PMCID: PMC5234813.
      Citations: 4     Fields:    Translation:Humans
    50. Edwards BJ, Sun M, West DP, Guindani M, Lin YH, Lu H, Hu M, Barcenas C, Bird J, Feng C, Saraykar S, Tripathy D, Hortobagyi GN, Gagel R, Murphy WA. Incidence of Atypical Femur Fractures in Cancer Patients: The MD Anderson Cancer Center Experience. J Bone Miner Res. 2016 08; 31(8):1569-76. PMID: 26896384.
      Citations: 10     Fields:    Translation:Humans
    51. Fayanju OM, Mayo TL, Spinks TE, Lee S, Barcenas CH, Smith BD, Giordano SH, Hwang RF, Ehlers RA, Selber JC, Walters R, Tripathy D, Hunt KK, Buchholz TA, Feeley TW, Kuerer HM. Value-Based Breast Cancer Care: A Multidisciplinary Approach for Defining Patient-Centered Outcomes. Ann Surg Oncol. 2016 08; 23(8):2385-90. PMID: 26979306.
      Citations: 11     Fields:    Translation:Humans
    52. Sanford RA, Lei X, Barcenas CH, Mittendorf EA, Caudle AS, Valero V, Tripathy D, Giordano SH, Chavez-MacGregor M. Impact of Time from Completion of Neoadjuvant Chemotherapy to Surgery on Survival Outcomes in Breast Cancer Patients. Ann Surg Oncol. 2016 May; 23(5):1515-21. PMID: 26678405.
      Citations: 23     Fields:    Translation:Humans
    53. Fujii T, Le Du F, Xiao L, Kogawa T, Barcenas CH, Alvarez RH, Valero V, Shen Y, Ueno NT. Effectiveness of an Adjuvant Chemotherapy Regimen for Early-Stage Breast Cancer: A Systematic Review and Network Meta-analysis. JAMA Oncol. 2015 Dec; 1(9):1311-8. PMID: 26402167; PMCID: PMC5575939.
      Citations: 28     Fields:    Translation:Humans
    54. Barcenas CH, Niu J, Zhang N, Zhang Y, Buchholz TA, Elting LS, Hortobagyi GN, Smith BD, Giordano SH. Risk of hospitalization according to chemotherapy regimen in early-stage breast cancer. J Clin Oncol. 2014 Jul 01; 32(19):2010-7. PMID: 24868022; PMCID: PMC4164758.
      Citations: 44     Fields:    Translation:Humans
    55. Delpech Y, Coutant C, Hsu L, Barranger E, Iwamoto T, Barcenas CH, Hortobagyi GN, Rouzier R, Esteva FJ, Pusztai L. Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas. Br J Cancer. 2013 Feb 05; 108(2):285-91. PMID: 23299541; PMCID: PMC3566807.
      Citations: 23     Fields:    Translation:Humans
    56. Barcenas CH, Zhang N, Zhao H, Duan Z, Buchholz TA, Hortobagyi GN, Giordano SH. Anthracycline regimen adherence in older patients with early breast cancer. Oncologist. 2012; 17(3):303-11. PMID: 22371383; PMCID: PMC3316913.
      Citations: 6     Fields:    Translation:Humans
    57. Barcenas CH, Wells J, Chong D, French J, Looney SW, Samuel TA. Race as an independent risk factor for breast cancer survival: breast cancer outcomes from the medical college of georgia tumor registry. Clin Breast Cancer. 2010 Feb; 10(1):59-63. PMID: 20133260.
      Citations: 14     Fields:    Translation:Humans
    58. Wilkinson AV, Forman MR, Etzel CJ, Cao Y, Strom SS, Spitz MR, Bondy ML, Hern?ndez-Valero MA, B?rcenas CH. Maternal BMI and country of birth as indicators of childhood obesity in children of Mexican origin. Obesity (Silver Spring). 2007 Oct; 15(10):2512-9. PMID: 17925478.
      Citations: 32     Fields:    Translation:Humans
    59. Barcenas CH, Wilkinson AV, Strom SS, Cao Y, Saunders KC, Mahabir S, Forman MR, Spitz MR, Bondy ML, Hern?ndez-Valero MA. Birthplace, years of residence in the United States, and obesity among Mexican-American adults. Obesity (Silver Spring). 2007 Apr; 15(4):1043-52. PMID: 17426341.
      Citations: 81     Fields:    Translation:Humans
    60. Mullen JT, Rodriguez-Bigas MA, Chang GJ, Barcenas CH, Crane CH, Skibber JM, Feig BW. Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma of the anal canal. Ann Surg Oncol. 2007 Feb; 14(2):478-83. PMID: 17103253.
      Citations: 25     Fields:    Translation:Humans
    61. Wilkinson AV, Etzel CJ, Barcenas CH, Spitz MR, Bondy ML, Strom SS, Hern?ndez-Valero MA. Self-Rated Health Among Adult Women of Mexican Origin. Hisp J Behav Sci. 2006 Feb; 28(1):127-142. PMID: 24600161; PMCID: PMC3940416.
      Citations: 2     
    62. Barcenas CH, Hosain GM, Arun B, Zong J, Zhou X, Chen J, Cortada JM, Mills GB, Tomlinson GE, Miller AR, Strong LC, Amos CI. Assessing BRCA carrier probabilities in extended families. J Clin Oncol. 2006 Jan 20; 24(3):354-60. PMID: 16421416.
      Citations: 33     Fields:    Translation:Humans
    63. Wilkinson AV, Spitz MR, Strom SS, Prokhorov AV, Barcenas CH, Cao Y, Saunders KC, Bondy ML. Effects of nativity, age at migration, and acculturation on smoking among adult Houston residents of Mexican descent. Am J Public Health. 2005 Jun; 95(6):1043-9. PMID: 15914831; PMCID: PMC1449306.
      Citations: 108     Fields:    Translation:Humans
    64. Barcenas CH, Delclos GL, El-Zein R, Tortolero-Luna G, Whitehead LW, Spitz MR. Wood dust exposure and the association with lung cancer risk. Am J Ind Med. 2005 Apr; 47(4):349-57. PMID: 15776474.
      Citations: 18     Fields:    Translation:Humans
    65. Are we able to predict survival in ER-positive HER2-negative breast cancer? A comparison of web-based models. Breast Diseases. 27:45-46.
    66. Impact of adjuvant chemotherapy on long-term employment of survivors of early-stage breast cancer. Breast Diseases. 26:90-92.
    67. Distant invasive breast cancer recurrence risk in human epidermal growth factor receptor 2-positive T1a and T1b node-negative localized breast cancer diagnosed from 2000 to 2006. Breast Diseases. 26:208-209.
    68. Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State. Breast Diseases. 27:36-38.
    69. Self-rated health among adult women of Mexican origin. Hispanic Journal of Behavioral Sciences. 28:127-142.
    70. Impact of Time from Completion of Neoadjuvant Chemotherapy to Surgery on Survival Outcomes in Breast Cancer Patients. Annals of Surgical Oncology. 1-7.
    71. Location of receipt of initial treatment and outcomes in long-term breast cancer survivors. PLoS One. 12.
    72. Value-Based Breast Cancer Care. Annals of Surgical Oncology. 1-6.
    BARCENAS's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (237)
    Co-Authors (108)
    Similar People (60)
    Same Department Expand Description